口腔悪性腫瘍組織浸潤リンパ球からの抗腫瘍活性の誘導に関する研究
スポンサーリンク
概要
- 論文の詳細を見る
Previous reports indicated that the histological intensity of the tumor infiltrating lymphocytes (TIL), which is one of the manifestations of immunological host's response against malignant tumor cells, correlates with the clinical prognosis of the cancer patients.<BR>In the present study, we investigated the antitumor cytotoxicity of TIL (or LN-TIL: lymphocytes of metastatic lymph node) induced by anti-CD3 antibody and interleukin 2 (IL-2), and the availability for the source of the adoptive immunotherapy on patients with oral malignant tumors.<BR>TIL were isolated from 28 tumors and LN-TIL were isolated from 6 metastatic lymph nodes obtained from 28 patients with oral malignant tumors.<BR>Natural killer (NK) and lymphokine-activated killer (LAK) activity of freshly isolated TIL were usually undetectable. However the antitumor cytotoxicity of TIL was generated with IL-2 <I>in vitro</I> culture. These activated TIL showed high levels of NK and LAK activities, and these were prolonged more than those of PBL.<BR>On the other hand, freshly isolated TIL from patients who received IL-2 injection directly into the tumor lesions before surgery, showed NK and LAK activities.<BR>The growth of TIL were obviously enhanced by using the plates coated with anti-CD3 antibody at the beginning of the culture.<BR>These activated TIL (or LN-TIL) with anti-CD3 antibody and/or IL-2 also showed the cytotoxicity against the autologous tumor cells.<BR>These results indicate that anti-CD3 antibody and IL-2 augment the specific and/or nonspecific cytotoxicity of the TIL (or LN-TIL) against the tumor cells, and this augmentation of cytotoxic activity shows the anti-tumoral efficacy for oral malignant tumors. Furthermore, TIL (or LN-TIL) from oral malignant tumors could be on appropriate effector cells for adoptive immunotherapy on the patients with oral malignant tumors.
- 社団法人 日本口腔外科学会の論文
著者
関連論文
- ニフェジピンおよびニフェジピンとシクロスポリンの併用により発症したと思われる歯肉増殖症の2例
- 口腔癌における旧N3症例 (UICC 1978年分類) の臨床的検討
- 口腔癌患者における抗CD3抗体およびIL2活性化自己リンパ球 (LAK細胞) の腫瘍集積性ならびに体内動態の観察
- 頬粘膜癌43例の臨床的検討
- 上顎悪性腫瘍の臨床統計的検討 : 上顎歯肉, 上顎洞, 硬口蓋の3者の比較
- 上顎癌における頸部リンパ節転移症例の臨床病理学的検討
- インターロイキン2活性化口腔癌患者末梢血リンパ球の自己新鮮腫瘍細胞に対する細胞障害活性
- 口腔悪性腫瘍組織浸潤リンパ球からの抗腫瘍活性の誘導に関する研究